Bioavailability: Why Formulation Matters Bioavailability is the lens through which we view every supplement decision
It activates GLP-1 receptors with strong potency and GIP receptors with even stronger potency
Restarting Semaglutide: Addressing Common Concerns Key Takeaways: Restarting semaglutide treatment requires careful planning and consultation with a healthcare provider to ensure safety and effectiveness
GLP-1 therapy starts at a low dose and titrates gradually to minimize gastrointestinal side effects the most common being nausea, particularly during dose increases
doi: 10.1007/s11916-025-01370-7
GLP-1 agonists, such as liraglutide and semaglutide, are increasingly used in medical weight loss due to their ability to mimic the natural hormone glucagon-like peptide-1, which is, for the most part, responsible for regulating appetite and food intake